Verve Therapeutics Inc (VERV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | |||
| Net Income | -19,297 | N/A | N/A |
| Depreciation Amortization | 34 | N/A | N/A |
| Accounts payable and accrued liabilities | 1,735 | N/A | N/A |
| Other Working Capital | 2,661 | N/A | N/A |
| Other Operating Activity | 7,425 | 0 | 0 |
| Operating Cash Flow | $-7,442 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||
| Change In Deposits | -10,901 | N/A | N/A |
| PPE Investments | -1,857 | N/A | N/A |
| Investing Cash Flow | $-12,758 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||
| Other Financing Activity | 17,954 | 0 | 0 |
| Financing Cash Flow | $17,954 | $N/A | $N/A |
| Beginning Cash Position | 5,467 | N/A | N/A |
| End Cash Position | 3,221 | N/A | N/A |
| Net Cash Flow | $-2,246 | $N/A | $N/A |
| Free Cash Flow | |||
| Operating Cash Flow | -7,442 | N/A | N/A |
| Capital Expenditure | -1,857 | N/A | N/A |
| Free Cash Flow | -9,299 | 0 | 0 |